Journal article
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
Kate Dolan, Andrea L Wirtz, Babak Moazen, Martial Ndeffo-mbah, Alison Galvani, Stuart A Kinner, Ryan Courtney, Martin McKee, Joseph J Amon, Lisa Maher, Margaret Hellard, Chris Beyrer, Fredrick L Altice
The Lancet | ELSEVIER SCIENCE INC | Published : 2016
Abstract
The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand the global epidemiology of HIV, hepatitis C virus (HCV), hepatitis B virus (HBV), and tuberculosis in prisoners. We further modelled the contribution of imprisonment and the potential impact of prevention interventions on HIV transmission in this population. Of the estimated 10·2 million people incarcerated worldwide on any given day in 2014, we estimated that 3·8% have HIV (389 000 living with HIV), 15·1% have HCV (1 546 500), 4·8% have chronic HBV (4..
View full abstractGrants
Awarded by Johns Hopkins University Center for AIDS Research, a National Institute of Health (NIH)
Awarded by Cancer Institute New South Wales Early Career Research Fellowship
Awarded by Australian National Health and Medical Research Council (NHMRC) Senior Research Fellowship
Awarded by NHMRC Senior Research Fellowship
Awarded by NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
Awarded by NATIONAL INSTITUTE ON DRUG ABUSE
Funding Acknowledgements
This paper was supported by grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from the National Institute on Drug Abuse; the Open Society Foundations; the United Nations Population Fund; Mac AIDS Fund; the Bill & Melinda Gates Foundation; and the Johns Hopkins University Center for AIDS Research, a National Institute of Health (NIH)-funded programme 1P30AI094189. KD was supported by Australia's National Drug and Alcohol Research Centre. RC is supported by a Cancer Institute New South Wales Early Career Research Fellowship (GNT14/ECF/1-46). SAK is supported by Australian National Health and Medical Research Council (NHMRC) Senior Research Fellowship (APP1078168). LM is supported by an NHMRC Senior Research Fellowship (APP1060443). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank Lori Rosman, Informationist at Johns Hopkins School Medicine, who assisted with the development of the systematic review; Teresa Ping Yeh and Natalie Flath, Johns Hopkins School of Public Health, who reviewed the identified articles and extracted data for the systematic review and meta-analysis; and Mary Kumvaj, Librarian, National Drug and Alcohol Research Centre, University of New South Wales who assisted with the grey literature search. We thank colleagues at the UN Office on Drugs and Crime, the European Monitoring Centre for Drugs and Drug Addiction, WHO, Glasgow Caledonian University, Health Protection Surveillance Centre (Ireland), Luxembourg Division de l'Inspection Sanitaire, National Advisory Committee on Drugs and Alcohol (Ireland), The National AIDS Centre (Poland), Public Health Agency of Catalonia, Trimbos Instituut, The University of Texas at Austin, Brandon Marshall, Brown University School of Public Health, Anna Bowring, Burnet Institute, and The UK Collaborating Centre for WHO Health in Prisons who contributed relevant reports and articles to the comprehensive review.